How Incyte Stock Became A Bull Market Star For Biotech Investors


Despite many twists and turns, the U.S. stock market has had a stupendous run since it reached a bottom in Mar 2009. The bull run has continued for eight years with the S&P 500 gaining 198.1% during this period.

While several stocks performed well during this period, Incyte Corporation (INCY – Free Report) tops the list — this bull market outperformer gained a whopping 5797.9% during this 8-year period, outperforming the Zacks-categorized Medical-Biomedical/Genetics industry as well as the S&P 500 by a huge margin.

So what are the factors that made Incyte a Wall Street favorite during this period?

Reviews

  • Total Score 0%
User rating: 0.00% ( 0
votes )



Leave a Reply

Your email address will not be published. Required fields are marked *